HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Intravenous dalargin as a method of increasing the effectiveness of blood reinfusion in the late stages of hemorrhagic shock].

Abstract
Acute experiments on 63 adult rabbits have shown that acute divided blood loss for 5 min (27 +/- 1% of the whole blood volume) results in the development of reversible hemorrhagic shock with survival of all the animals. In the same volume of continuous blood exfusion (27 +/- 5% of blood volume) or an increase in blood loss to 43 +/- 2% of blood volume hemorrhagic shock proved irreversible. Early reinfusion of heparinized blood saved all the animals, whereas late reinfusions only prolonged the survival. Intravenous administration of dalargin (0.1 mg/kg) in late shock was not effective and all the animals died. Dalargin introduction after blood reinfusion in late shock saved the animals lives. The conclusion is made on benefits of intravenous dalargin for raising the efficacy of reinfusions (hemotransfusion) at late stages of severe hemorrhagic shock.
AuthorsD M Sherman, V M Trach
JournalGematologiia i transfuziologiia (Gematol Transfuziol) 1993 Sep-Oct Vol. 38 Issue 8 Pg. 27-30 ISSN: 0234-5730 [Print] Russia (Federation)
Vernacular TitleVnutrivennye vvedeniia dalargina kak metod povysheniia éffektivnosti reinfuzii krovi v pozdnem periode gemorragicheskogo shoka.
PMID8307301 (Publication Type: Journal Article)
Chemical References
  • Enkephalin, Leucine-2-Alanine
  • enkephalin-Leu, Ala(2)-Arg(6)-
Topics
  • Animals
  • Blood Transfusion
  • Combined Modality Therapy
  • Enkephalin, Leucine-2-Alanine (administration & dosage, analogs & derivatives)
  • Injections, Intravenous
  • Rabbits
  • Shock, Hemorrhagic (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: